NARCOTICS ANALGESICS MARKET ANALYSIS

Regional Analysis

Narcotics Analgesics Market – Regional Analysis

On the basis of region, the global narcotics analgesics market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Geographically, North America is likely to lead in the global narcotics analgesics market owing to rising misuse of opioid analgesics. For instance, according to the Federal Government of U.S., in 2015, 8.5 million people i.e. 3% of the population of U.S. misused opioid painkillers in 2015, and 2.5 million were addicted to either painkillers or heroin in 2015. Moreover, More than 33,000 people died from overdoses of opioid drugs in 2015.

Europe region is also expected to perceive extensive growth in global narcotics analgesics market since few countries in the European Union are misusing prescription opioid analgesics as normal pain killers which is not advisable since these are habit forming drugs. For instance, according to BMC Psychiatry journal August 2016, Spain had the highest use of opioids for non-medical purposes, and Great Britain had the second-highest opioid users.

The key players operating in narcotics analgesics market include, Pfizer Inc., Teva Pharmaceuticals, Allergan plc, BioDelivery Sciences International, Inc., Endo Pharmaceuticals, Inc., Akron, Inc., UCB, Inc., Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, and Janssen Pharmaceuticals, Inc.